Zobrazeno 91 - 100
of 107
pro vyhledávání: '"Daniel S Chen"'
Autor:
Michael S. Gordon, Y. Xin, Lee S. Rosen, E. Wakshull, Shuang Bai, L. Naumovski, Daniel S. Chen, D. Jin, Pamela N. Munster
Publikováno v:
Journal of Clinical Oncology. 29:2586-2586
2586 Background: Monoclonal antibody therapeutics in oncology are most frequently dosed using body weight (BW)-based dosing, which may be due to the perception that BW-based dosing may be more prec...
Autor:
E. Ashton, Daniel S. Chen, Michael S. Gordon, Lee S. Rosen, Pamela N. Munster, Jill Fredrickson, Michel Friesenhahn, Ilsung Chang, L. Naumovski, A. de Crespigny
Publikováno v:
Journal of Clinical Oncology. 29:2539-2539
2539 Background: DCE-MRI allows for the functional analysis of tumor microcirculation and composition, and has been used to evaluate changes in vascular parameters in response to anti-angiogenic ag...
Publikováno v:
Clinical Cancer Research. 16:PR3-PR3
Background: Evaluation of cancer biomarkers from blood and other accessible tissues could significantly enable biomarker assessment by providing a relatively noninvasive source of representative tumor material. Circulating tumor cells (CTCs) isolated
Autor:
Daniel S. Chen, Hoa Nguyen, M. Schmidt, Amy C. Peterson, P. Cheverton, Stefan Scherer, Steven J. O'Day, Priti S. Hegde, B. Xing, Kevin B. Kim
Publikováno v:
Journal of Clinical Oncology. 28:10563-10563
10563 Background: Bevacizumab, a monoclonal antibody targeted against vascular endothelial growth factor A (VEGF), showed a clinically significant benefit in the analysis of a large (n=214) randomi...
Autor:
Hartmut Koeppen, Stefan Scherer, M. Zheng, D.S. Chen, Adrian M. Jubb, Daniel S. Chen, Priti S. Hegde, Eric Holmgren, Coen Bernaards
Publikováno v:
Journal of Clinical Oncology. 28:10519-10519
10519 Background: Bevacizumab, a monoclonal antibody against vascular endothelial growth factor A (VEGF), has shown significant clinical benefit in a number of advanced or metastatic cancer settings. We assessed the value of circulating VEGF level as
Autor:
Elizabeth Punnoose, Daniel S. Chen, Ajay Pandita, Jill M. Spoerke, Heidi Savage, Sankar Mohan, Siminder K. Atwal, Mark R. Lackner
Publikováno v:
Cancer Research. 70:5768-5768
Introduction: Tumor tissue collection is essential for biomarker assessment but can be difficult in tumor types such as non small-cell lung cancer (NSCLC) where often no surgery is performed and diagnosis is done with biopsies yielding only very limi
Publikováno v:
Journal of Clinical Oncology. 22:9507-9507
9507 Background: Current standards in pathological diagnosis are based on tissue of origin, microscopic examination, immunohistochemistry and immunophenotyping. This leads to a most likely diagnosis utilizing minimal acceptable resources, ignoring po
Autor:
Yoav Soen, Mark M. Davis, Peter P. Lee, Jeffrey S. Weber, Tor B. Stuge, Daniel S. Chen, Patrick O. Brown
Publikováno v:
Journal of Clinical Oncology. 22:2510-2510
2510 Background: Immune based therapies that evoke a T cell response against tumor-specific antigens is an attractive therapeutic approach. However, the ongoing development of such therapies, which...
Publikováno v:
PLoS Biology, Vol 1, Iss 3, p E65 (2003)
The detection and characterization of antigen-specific T cell populations is critical for understanding the development and physiology of the immune system and its responses in health and disease. We have developed and tested a method that uses array
Autor:
Chiung-Hung Chang, Yueh-Sheng Chen, Ming-Tang Chiou, Chiu-Hsian Su, Daniel S. Chen, Chin-En Tsai, Bi Yu, Yuan-Man Hsu
Publikováno v:
Evidence-based Complementary & Alternative Medicine (eCAM); 2013, Vol. 2013, p1-8, 8p, 2 Charts, 5 Graphs